Practice
Featured experience
Cerebras Systems $6.4 billion IPO
We advised the underwriters on the IPO
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Arxis $1.3 billion IPO
We advised Arxis on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Moderna $3 billion convertible notes offering and capped call transactions
We advised the initial purchasers on the offering
Banco Santander $2 billion notes offering
We advised Banco Santander on the offering
First Eagle Investments $7 billion sale to Victory Capital
We are advising First Eagle Investments’ management on the transaction
Immatics $172.5 million follow-on offering
We advised Immatics on the offering
Backblaze $201.25 million convertible notes offering
We advised the representative of the initial purchasers on the offering
Aveanna $203 million secondary offering
We advised the underwriters on the offering
Oruka Therapeutics $500 million at-the-market offering
We advised Oruka on the offering
Londian Wason $94.3 million IPO
We advised Londian Wason on its IPO and NYSE listing
Castelion $800 million Series C financing
We advised JPMorganChase as co-lead investor in the round
Dynatrace $1.4375 billion exchangeable senior notes offering
We advised the initial purchasers on the offering